Rankings
▼
Calendar
ELAN Q4 2022 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q4 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$988M
-11.2% YoY
Gross Profit
$410M
41.5% margin
Operating Income
$27M
2.7% margin
Net Income
-$54M
-5.5% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
-3.7%
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
-$66M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$15.5B
Total Liabilities
$8.2B
Stockholders' Equity
$7.3B
Cash & Equivalents
$345M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$988M
$1.1B
-11.2%
Gross Profit
$410M
$462M
-11.3%
Operating Income
$27M
$43M
-37.2%
Net Income
-$54M
-$104M
+48.1%
Revenue Segments
Farm Animal
$552M
27%
Cattle
$469M
23%
Pet Health
$416M
21%
Poultry
$366M
18%
Swine
$200M
10%
Contract Manufacturing
$13M
1%
Geographic Segments
Non-US
$552M
56%
UNITED STATES
$429M
44%
← FY 2022
All Quarters
Q1 2023 →